Deciphera Pharmaceuticals, Inc. Operating Income
Deciphera Pharmaceuticals, Inc. reported Operating Income of -$48.85 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-05-10
- Deciphera Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2024-03-31 was -$48.85M.
- Deciphera Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2023-12-31 was -$51.24M.
- Deciphera Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2023-09-30 was -$53.69M.
- Deciphera Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2023-06-30 was -$52.77M.
- Deciphera Pharmaceuticals, Inc. operating income (loss) for fiscal 2023 was -$210.96M.
- Deciphera Pharmaceuticals, Inc. operating income (loss) for fiscal 2022 was -$182.72M.
- Deciphera Pharmaceuticals, Inc. operating income (loss) for fiscal 2021 was -$300.08M.
- Deciphera Pharmaceuticals, Inc. operating income (loss) for fiscal 2020 was -$271.19M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$48.85M 10-Q · filed 2024-05-10 | -$100.08M derived: sum of 2 quarters · filed 2024-05-10 | -$153.77M derived: sum of 3 quarters · filed 2024-05-10 | -$206.55M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | -$51.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$104.93M derived: sum of 2 quarters · filed 2024-02-07 | -$157.70M derived: sum of 3 quarters · filed 2024-02-07 | -$210.96M 10-K · filed 2024-02-07 |
| 2023-09-30 | -$53.69M 10-Q · filed 2023-10-30 | -$106.46M derived: sum of 2 quarters · filed 2023-10-30 | -$159.72M 10-Q · filed 2023-10-30 | -$206.88M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | -$52.77M 10-Q · filed 2023-08-09 | -$106.03M 10-Q · filed 2023-08-09 | -$153.19M derived: sum of 3 quarters · filed 2024-05-10 | -$198.07M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | -$53.26M 10-Q · filed 2024-05-10 | -$100.42M derived: sum of 2 quarters · filed 2024-05-10 | -$145.30M derived: sum of 3 quarters · filed 2024-05-10 | -$189.09M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$47.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$92.04M derived: sum of 2 quarters · filed 2024-02-07 | -$135.83M derived: sum of 3 quarters · filed 2024-02-07 | -$182.72M 10-K · filed 2024-02-07 |
| 2022-09-30 | -$44.88M 10-Q · filed 2023-10-30 | -$88.67M derived: sum of 2 quarters · filed 2023-10-30 | -$135.56M 10-Q · filed 2023-10-30 | -$223.96M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | -$43.79M 10-Q · filed 2023-08-09 | -$90.68M 10-Q · filed 2023-08-09 | -$179.08M derived: sum of 3 quarters · filed 2024-02-07 | -$258.75M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | -$46.89M 10-Q · filed 2023-05-03 | -$135.29M derived: sum of 2 quarters · filed 2024-02-07 | -$214.96M derived: sum of 3 quarters · filed 2024-02-07 | -$285.48M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | -$88.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$168.07M derived: sum of 2 quarters · filed 2024-02-07 | -$238.58M derived: sum of 3 quarters · filed 2024-02-07 | -$300.08M 10-K · filed 2024-02-07 |
| 2021-09-30 | -$79.67M 10-Q · filed 2022-11-03 | -$150.18M derived: sum of 2 quarters · filed 2022-11-03 | -$211.68M 10-Q · filed 2022-11-03 | -$274.68M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$70.51M 10-Q · filed 2022-08-04 | -$132.01M 10-Q · filed 2022-08-04 | -$195.01M derived: sum of 3 quarters · filed 2022-08-04 | -$259.00M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$61.49M 10-Q · filed 2022-05-04 | -$124.49M derived: sum of 2 quarters · filed 2022-05-04 | -$188.49M derived: sum of 3 quarters · filed 2022-05-04 | -$257.42M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | -$63.00M 10-K · filed 2021-02-09 | -$127.00M derived: sum of 2 quarters · filed 2021-11-02 | -$195.93M derived: sum of 3 quarters · filed 2021-11-02 | -$271.19M 10-K · filed 2023-02-07 |
| 2020-09-30 | -$64.00M 10-Q · filed 2021-11-02 | -$132.93M derived: sum of 2 quarters · filed 2021-11-02 | -$208.19M 10-Q · filed 2021-11-02 | -$278.56M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | -$68.93M 10-Q · filed 2021-08-03 | -$144.19M 10-Q · filed 2021-08-03 | -$214.57M derived: sum of 3 quarters · filed 2021-08-03 | -$272.92M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | -$75.26M 10-Q · filed 2021-05-04 | -$145.63M derived: sum of 2 quarters · filed 2021-05-04 | -$203.99M derived: sum of 3 quarters · filed 2021-05-04 | -$226.96M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | -$70.37M 10-K · filed 2021-02-09 | -$128.73M derived: sum of 2 quarters · filed 2021-02-09 | -$151.70M derived: sum of 3 quarters · filed 2021-02-09 | -$200.73M 10-K · filed 2022-02-08 |
| 2019-09-30 | -$58.35M 10-K · filed 2021-02-09 | -$81.33M derived: sum of 2 quarters · filed 2021-02-09 | -$130.35M 10-Q · filed 2020-11-05 | -$164.18M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | -$22.98M 10-K · filed 2021-02-09 | -$72.00M 10-Q · filed 2020-08-04 | -$105.83M derived: sum of 3 quarters · filed 2021-02-09 | -$131.72M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | -$49.02M 10-K · filed 2021-02-09 | -$82.86M derived: sum of 2 quarters · filed 2021-02-09 | -$108.74M derived: sum of 3 quarters · filed 2021-02-09 | -$131.17M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | -$33.83M 10-K · filed 2020-03-09 | -$59.72M derived: sum of 2 quarters · filed 2020-03-09 | -$82.15M derived: sum of 3 quarters · filed 2020-03-09 | -$104.10M 10-K · filed 2021-02-09 |
| 2018-09-30 | -$25.89M 10-K · filed 2020-03-09 | -$48.32M derived: sum of 2 quarters · filed 2020-03-09 | -$70.27M 10-Q · filed 2019-11-04 | -$90.61M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | -$22.43M 10-K · filed 2020-03-09 | -$44.38M 10-Q · filed 2019-08-02 | -$64.72M derived: sum of 3 quarters · filed 2020-03-09 | -$76.90M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | -$21.95M 10-K · filed 2020-03-09 | -$42.29M derived: sum of 2 quarters · filed 2020-03-09 | -$54.47M derived: sum of 3 quarters · filed 2020-03-09 | -$65.16M derived: sum of 4 quarters · filed 2020-03-09 |
| 2017-12-31 | -$20.34M 10-K · filed 2019-03-14 | -$32.52M derived: sum of 2 quarters · filed 2019-03-14 | -$43.21M derived: sum of 3 quarters · filed 2019-03-14 | -$50.94M 10-K · filed 2020-03-09 |
| 2017-09-30 | -$12.18M 10-K · filed 2019-03-14 | -$22.87M derived: sum of 2 quarters · filed 2019-03-14 | -$30.60M 10-Q · filed 2018-11-08 | -$39.13M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | -$10.69M 10-K · filed 2019-03-14 | -$18.42M 10-Q · filed 2018-08-07 | -$26.95M derived: sum of 3 quarters · filed 2019-03-14 | -$33.02M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | -$7.72M 10-K · filed 2019-03-14 | -$16.26M derived: sum of 2 quarters · filed 2019-03-14 | -$22.33M derived: sum of 3 quarters · filed 2019-03-14 | -$28.24M derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | -$8.53M 10-K · filed 2018-03-28 | -$14.60M derived: sum of 2 quarters · filed 2018-03-28 | -$20.51M derived: sum of 3 quarters · filed 2018-03-28 | -$25.84M 10-K · filed 2019-03-14 |
| 2016-09-30 | -$6.07M 10-K · filed 2018-03-28 | -$11.98M derived: sum of 2 quarters · filed 2018-03-28 | -$17.30M derived: sum of 3 quarters · filed 2018-03-28 | |
| 2016-06-30 | -$5.91M 10-K · filed 2018-03-28 | -$11.24M derived: sum of 2 quarters · filed 2018-03-28 | ||
| 2016-03-31 | -$5.32M 10-K · filed 2018-03-28 | |||
| 2015-12-31 | -$17.61M 10-K · filed 2018-03-28 |